Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.7 |